217 related articles for article (PubMed ID: 31973044)
21. Characterization of Anopheles gambiae D7 salivary proteins as markers of human-mosquito bite contact.
Oseno B; Marura F; Ogwang R; Muturi M; Njunge J; Nkumama I; Mwakesi R; Mwai K; Rono MK; Mwakubambanya R; Osier F; Tuju J
Parasit Vectors; 2022 Jan; 15(1):11. PubMed ID: 34996508
[TBL] [Abstract][Full Text] [Related]
22. Anopheles gambiae salivary protein expression modulated by wild Plasmodium falciparum infection: highlighting of new antigenic peptides as candidates of An. gambiae bites.
Marie A; Holzmuller P; Tchioffo MT; Rossignol M; Demettre E; Seveno M; Corbel V; Awono-Ambéné P; Morlais I; Remoue F; Cornelie S
Parasit Vectors; 2014 Dec; 7():599. PubMed ID: 25526764
[TBL] [Abstract][Full Text] [Related]
23. An insight into immunogenic salivary proteins of Anopheles gambiae in African children.
Cornelie S; Remoue F; Doucoure S; Ndiaye T; Sauvage FX; Boulanger D; Simondon F
Malar J; 2007 Jun; 6():75. PubMed ID: 17550586
[TBL] [Abstract][Full Text] [Related]
24. Use of an Anopheles Salivary Biomarker to Assess Malaria Transmission Risk Along the Thailand-Myanmar Border.
Ya-Umphan P; Cerqueira D; Parker DM; Cottrell G; Poinsignon A; Remoue F; Brengues C; Chareonviriyaphap T; Nosten F; Corbel V
J Infect Dis; 2017 Feb; 215(3):396-404. PubMed ID: 27932615
[TBL] [Abstract][Full Text] [Related]
25. Novel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites.
Poinsignon A; Cornelie S; Mestres-Simon M; Lanfrancotti A; Rossignol M; Boulanger D; Cisse B; Sokhna C; Arcà B; Simondon F; Remoue F
PLoS One; 2008 Jun; 3(6):e2472. PubMed ID: 18575604
[TBL] [Abstract][Full Text] [Related]
26. Exploring the heterogeneity of human exposure to malaria vectors in an urban setting, Bouaké, Côte d'Ivoire, using an immuno-epidemiological biomarker.
Traoré DF; Sagna AB; Adja AM; Zoh DD; Adou KA; Lingué KN; Coulibaly I; Tchiekoi NB; Assi SB; Poinsignon A; Dagnogo M; Remoue F
Malar J; 2019 Mar; 18(1):68. PubMed ID: 30857543
[TBL] [Abstract][Full Text] [Related]
27. Relationship between exposure to vector bites and antibody responses to mosquito salivary gland extracts.
Fontaine A; Pascual A; Orlandi-Pradines E; Diouf I; Remoué F; Pagès F; Fusaï T; Rogier C; Almeras L
PLoS One; 2011; 6(12):e29107. PubMed ID: 22195000
[TBL] [Abstract][Full Text] [Related]
28. Plasmodium falciparum infection during dry season: IgG responses to Anopheles gambiae salivary gSG6-P1 peptide as sensitive biomarker for malaria risk in Northern Senegal.
Sagna AB; Gaayeb L; Sarr JB; Senghor S; Poinsignon A; Boutouaba-Combe S; Schacht AM; Hermann E; Faye N; Remoue F; Riveau G
Malar J; 2013 Aug; 12():301. PubMed ID: 23988032
[TBL] [Abstract][Full Text] [Related]
29. Detection of immunogenic proteins from Anopheles sundaicus salivary glands in the human serum.
Armiyanti Y; Nuryady MM; Arifianto RP; Nurmariana E; Senjarini K; Fitri LE; Sardjono TW
Rev Soc Bras Med Trop; 2015; 48(4):410-6. PubMed ID: 26312930
[TBL] [Abstract][Full Text] [Related]
30. Variation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands.
Badu K; Siangla J; Larbi J; Lawson BW; Afrane Y; Ong'echa J; Remoue F; Zhou G; Githeko AK; Yan G
Malar J; 2012 Sep; 11():318. PubMed ID: 22963464
[TBL] [Abstract][Full Text] [Related]
31. Specific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites.
Drame PM; Poinsignon A; Dechavanne C; Cottrell G; Farce M; Ladekpo R; Massougbodji A; Cornélie S; Courtin D; Migot-Nabias F; Garcia A; Remoué F
Malar J; 2015 Jul; 14():285. PubMed ID: 26198354
[TBL] [Abstract][Full Text] [Related]
32. Aedes aegypti anti-salivary gland antibody concentration and dengue virus exposure history in healthy individuals living in an endemic area in Colombia.
Londoño-Rentería B; Cárdenas JC; Giovanni JE; Cárdenas L; Villamizar P; Rolón J; Chisenhall DM; Christofferson RC; Carvajal DJ; Pérez OG; Wesson DM; Mores CN
Biomedica; 2015; 35(4):572-81. PubMed ID: 26844447
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the effectiveness of malaria vector control measures in urban settings of Dakar by a specific anopheles salivary biomarker.
Drame PM; Diallo A; Poinsignon A; Boussari O; Dos Santos S; Machault V; Lalou R; Cornelie S; LeHesran JY; Remoue F
PLoS One; 2013; 8(6):e66354. PubMed ID: 23840448
[TBL] [Abstract][Full Text] [Related]
34. IgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.
Stone W; Bousema T; Jones S; Gesase S; Hashim R; Gosling R; Carneiro I; Chandramohan D; Theander T; Ronca R; Modiano D; Arcà B; Drakeley C
PLoS One; 2012; 7(6):e40170. PubMed ID: 22768250
[TBL] [Abstract][Full Text] [Related]
35. Specific human antibody responses to Aedes aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to disease vectors in the Pacific.
Mathieu-Daudé F; Claverie A; Plichart C; Boulanger D; Mphande FA; Bossin HC
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006660. PubMed ID: 30040826
[TBL] [Abstract][Full Text] [Related]
36. Immunoglobulin G antibody profiles against Anopheles salivary proteins in domestic animals in Senegal.
Boulanger D; Doucoure S; Grout L; Ngom A; Rogerie F; Cornelie S; Sokhna C; Mouchet F; Riveau G; Simondon F; Remoue FJ
J Med Entomol; 2011 May; 48(3):691-3. PubMed ID: 21661332
[TBL] [Abstract][Full Text] [Related]
37. Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control.
Drame PM; Poinsignon A; Besnard P; Cornelie S; Le Mire J; Toto JC; Foumane V; Dos-Santos MA; Sembène M; Fortes F; Simondon F; Carnevale P; Remoue F
PLoS One; 2010 Dec; 5(12):e15596. PubMed ID: 21179476
[TBL] [Abstract][Full Text] [Related]
38. First attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites.
Poinsignon A; Samb B; Doucoure S; Drame PM; Sarr JB; Sow C; Cornelie S; Maiga S; Thiam C; Rogerie F; Guindo S; Hermann E; Simondon F; Dia I; Riveau G; Konate L; Remoue F
Trop Med Int Health; 2010 Oct; 15(10):1198-203. PubMed ID: 20723184
[TBL] [Abstract][Full Text] [Related]
39. Mosquito bites and stage-specific antibody responses against Plasmodium falciparum in southern Ghana.
Kwapong SS; Asare KK; Kusi KA; Pappoe F; Ndam N; Tahar R; Poinsignon A; Amoah LE
Malar J; 2023 Apr; 22(1):126. PubMed ID: 37061695
[TBL] [Abstract][Full Text] [Related]
40. Wide cross-reactivity between Anopheles gambiae and Anopheles funestus SG6 salivary proteins supports exploitation of gSG6 as a marker of human exposure to major malaria vectors in tropical Africa.
Rizzo C; Ronca R; Fiorentino G; Mangano VD; Sirima SB; Nèbiè I; Petrarca V; Modiano D; Arcà B
Malar J; 2011 Jul; 10():206. PubMed ID: 21794142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
